Culture

The Lancet: Most patients hospitalised with COVID-19 have at least one symptom six months after falling ill, Wuhan follow-up study suggests

Study of 1,733 patients first diagnosed in Wuhan (China) between January and May followed to June and September.

76% of COVID-19 patients have at least one symptom six months after symptom onset.

Fatigue or muscle weakness is the most common symptom, with sleep difficulties and anxiety or depression also frequently reported.

Lower antibodies against COVID-19 in patients six months after becoming ill compared with during acute infection raises concerns about the possibility of re-infection.

More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.

The cohort study, looking at long-term effects of COVID-19 infection on people hospitalised in Wuhan, China, reveals that the most common symptom to persist is fatigue or muscle weakness (63% of patients), with patients also frequently experiencing sleep difficulties (26%). Anxiety or depression was reported among 23% of patients.

Patients who were severely ill in hospital more often had impaired lung function and abnormalities detected in chest imaging - which could indicate organ damage - six months after symptom onset.

Levels of neutralising antibodies fell by more than half (52.5%) after six months in 94 patients whose immune response was tested at the peak of the infection, raising concerns about the possibility of being re-infected by the virus.

Little is known about the long-term health effects of COVID-19 as few follow-up studies have so far been carried out. Those that have been conducted looked only at a small number of cases over a short follow-up period (typically around three months after discharge).

Professor Bin Cao, from National Center for Respiratory Medicine, China-Japan Friendship Hospital and Capital Medical University, said: "Because COVID-19 is such a new disease, we are only beginning to understand some of its long-term effects on patients' health. Our analysis indicates that most patients continue to live with at least some of the effects of the virus after leaving hospital, and highlights a need for post-discharge care, particularly for those who experience severe infections. Our work also underscores the importance of conducting longer follow-up studies in larger populations in order to understand the full spectrum of effects that COVID-19 can have on people." [1]

The new study included 1,733 COVID-19 patients who were discharged from Jin Yin-tan Hospital in Wuhan, China, between January 7th and May 29th 2020. Patients had a median age of 57 years. Follow-up visits were done from June 16th to September 3rd, 2020, and the median follow-up time was 186 days.

All patients were interviewed face-to-face using questionnaires to evaluate their symptoms and health-related quality of life. They also underwent physical examinations, lab tests, and a six-minute walking test to gauge patients' endurance levels. 390 patients had further tests, including an assessment of their lung function. In addition, 94 patients whose blood antibody levels were recorded at the height of the infection as part of another trial received a follow-up test.

At follow-up, 76% of patients (1,265/1,655) reported at least one ongoing symptom. Fatigue or muscle weakness was reported by 63% (1,038/1,655), while 26% (437/1,655) had sleep difficulties and 23% (367/1,733) experienced anxiety or depression.

Of the 390 patients who underwent additional testing, 349 completed the lung function test (41 were unable to complete the test due to poor compliance). Patients with more severe illness commonly had reduced lung function, with 56% (48/86) of those at severity scale 5-6 (who required ventilation) experiencing diffusion impairment - reduced flow of oxygen from the lungs to the bloodstream. For patients at severity scale 4 (who required oxygen therapy) and those at scale 3 (who did not require oxygen therapy) the figures were 29% (48/165) and 22% (18/83), respectively.

Patients with more severe disease performed worse in the six-minute walking test (which measures the distance covered in six minutes), with 29% of those at severity scale 5-6 walking less than the lower limit of the normal range, compared with 24% for those at scale 3, and 22% for scale 4.

The authors also found that some patients went on to develop kidney problems post-discharge. As well as the lungs, COVID-19 is known to affect other organs, including the kidney. Lab tests revealed that 13% (107/822) of patients whose kidney function was normal while in hospital had reduced kidney function in follow-up.

Follow-up blood antibody tests from 94 patients after six months revealed that levels of neutralising antibodies were 52.5% lower than at the height of infection. The authors say this raises concerns about the possibility of COVID-19 re-infection.

As the number of participants with antibody test results both at acute phase and follow-up was limited, larger samples are needed in future to clarify how levels of antibodies against the virus change over time. Further work is also needed to compare differences in outcomes between inpatients and outpatients, as patients with mild COVID-19 symptoms who stayed in temporary Fangcang shelter hospitals were not included in the study.

Impaired lung function and exercise capacity observed in the study cannot be directly attributed to COVID-19 as baseline data for these are unavailable. Due to the way the data was analysed, it also was not possible to determine if symptoms reported during follow-up were persistent following the infection, worsened after recovery, or occurred post-discharge.

Writing in a linked Comment, Monica Cortinovis, Norberto Perico, and Giuseppe Remuzzi, from the Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy, who were not involved in the study, remark on the uncertainty regarding the possible long-term impacts of COVID-19 on health, saying: "Unfortunately, there are few reports on the clinical picture of the aftermath of COVID-19. The study by Huang and colleagues in The Lancet is therefore relevant and timely."

Echoing the study authors' calls for further research, they add: "Even though the study offers a comprehensive clinical picture of the aftermath of COVID-19 in hospitalised patients, only 4% were admitted to an intensive care unit (ICU), rendering the information about the long-term consequences in this particular cohort inconclusive. Nonetheless, previous research on patient outcomes after ICU stays suggests that several COVID-19 patients who were critically ill while hospitalised will subsequently face impairments regarding their cognitive and mental health and/or physical function far beyond their hospital discharge."

Credit: 
The Lancet

New tech helping cancer patients manage symptoms

image: Hands at a computer

Image: 
Stevepb/pixabay

Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.

The early stage colorectal, breast or gynecological cancer patients took part in the trial of the eRAPID system, developed by the University of Leeds, which allowed them to report online symptoms from home and receive instant advice on whether to self-manage or seek medical attention.

Patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Patients reported more confidence in managing their health at the end of their four-month trial period.

The results demonstrate that improvements to patients' physical wellbeing can be achieved in a cost-effective way without increasing clinicians' workload.

It is the first such trial to offer automated advice, and one of only a few to focus mainly on early-stage patients whose treatment aims to cure the cancer.

Programme lead Professor Galina Velikova, at the Leeds Institute of Medical Research at St James's, University of Leeds, and the Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, said: "Rising numbers of cancer patients are receiving a range of anti-cancer treatments which means patients are living longer and require longer periods of care and monitoring.

"Remote online monitoring options have the potential to be a patient-centred, safe and effective approach to support patients during cancer treatment and manage the growing clinical workload for cancer care."

Dr Kate Absolom, University Academic Fellow in the Leeds Institute of Medical Research at St James's and the Leeds Institute of Health Sciences at the University of Leeds, said: "The encouraging results from this study will help pave the way for future development and refinement of these interventions in broader cancer settings. The COVID19 pandemic highlighted the need and speeded a shift towards technology-enabled care, so these study results are very timely."

Cancer patients can experience a range of symptoms, which can be caused by the cancer itself, by other conditions, or by side effects from chemotherapy and other treatments, which are sometimes life threatening and require emergency hospitalisation.

Symptoms can significantly lower patients' quality of life. Better monitoring and management can improve treatment delivery and reduce patients' physical distress.

Funded by the National Institute for Health Research (NIHR), the eRAPID trial set out to establish whether symptom control could be improved using automated advice, to try to improve patients' wellbeing. It included 508 patients aged 18 to 86 who were starting chemotherapy at Leeds Cancer Centre. All patients received their usual care, with 256 receiving the eRAPID system as additional care.

Participants answered a set of cancer specific questions through an online symptom report once a week, or when new symptoms emerged, over the 18-week study period. Using symptom severity grades, a computer algorithm designed by the researchers and clinicians scored all the responses and determined the advice patients received.

Questions covered pain levels, nausea, spending time in bed and not meeting family needs. Participants received immediate advice on symptom management or a prompt to contact the hospital. Symptom reports were immediately displayed in the patients' electronic records, and email alerts for severe symptom reports were sent directly to clinicians.

A total of 3,314 online reports were completed, reporting 18,867 individual symptoms - an average of 13 reports per patient. Emergency alerts were sent 29 times (under 1%), while serious symptoms not requiring immediate medical attention were reported on 461 occasions (14%). More than 80% of self-reported symptoms triggered self-management advice, providing a cost-effective solution with better outcomes for patients.

Clinical benefits in patients' physical wellbeing were seen particularly at the early period of treatment, between weeks 6 and 12, when challenges in controlling side-effects are expected.

The immediate advice increased patient confidence in managing the mild and moderate treatment-related symptoms, which can significantly impact patients' quality of life and ability to continue treatment.

And trial data showed no increase in hospital workload, no differences in chemotherapy delivery, and no compromise of patient safety.

Julia Brown, Professor of Clinical Trials Research and Director of the University of Leeds Institute of Clinical Trials Research, in the School of Medicine, said: "This study provides timely and important evidence that remote real-time monitoring of cancer patients, particularly essential during pandemic conditions, is feasible and can improve patients' physical wellbeing."

Credit: 
University of Leeds

Latina mothers, often essential workers, report COVID-19 took toll

image: Financial and psychological toll: The pandemic has forced more than 50 percent of the families in a regional study to make economic cutbacks.

Image: 
UC Davis

More than half of Latina mothers surveyed in Yolo and Sacramento counties reported making economic cutbacks in response to the pandemic shutdown last spring -- saying they bought less food and missed rent payments. Even for mothers who reported receiving the federal stimulus payment during this time, these hardships were not reduced, University of California, Davis, researchers found in a recent study.

"Latino families are fighting the pandemic on multiple fronts, as systemic oppression has increased their likelihood of contracting the virus, having complications from the virus and having significant economic hardship due to the virus," said Leah C. Hibel, associate professor of human development and family studies at UC Davis and lead author of the study. "These factors are likely to have a significant psychological toll on these families."

The study was published Jan. 7 in the journal Traumatology. Researchers administered surveys to 70 Latina mothers March 18 through June 5 of last spring, after the "shelter-in-place" orders went into effect in California in response to the COVID-19 pandemic.

The survey sample consisted of Latina mothers, all of whom are low-income, with 92 percent of the families having an essential worker (either the mother or her partner), in Yolo and Sacramento counties, researchers said. The survey respondents were identified through an earlier UC Davis study on Mexican-origin families living in the region. Yolo and Sacramento counties are in Northern California, which has a higher cost of living than most of the country, but has a relatively high level of social services available, researchers added.

Researchers said that although it has been reported that the stimulus checks may have kept some from falling below the poverty level, cutbacks due to other economic factors still had an effect on these low-income families.

"In other words, though the stimulus may have prevented some families from falling below the poverty line, our analyses suggest that many low-income families are still facing significant financial hardship," researchers said in the study. "This hardship appears to be placing families on a trajectory toward hunger and eviction."

Less food, higher stress

Mothers who engaged in cutbacks reported significantly higher levels of stress, depression, and anxiety. Further, receiving the federal stimulus money administered to those whose income was less than $99,000 a year (through the Coronavirus Aid, Relief, and Economic Security Act) was not associated with lower cutbacks, stress, depression or anxiety. Of those surveyed, 65 percent had reported receiving their checks by the time the survey was administered.

Mothers' depressive symptoms were assessed through survey questions administered by phone. Most were in English, but in some cases, questions were asked in Spanish by native-speaking interviewers. Assessed on a five-point answer scale, mothers were asked such questions as:

"How stressed are you because of the virus outbreak?"

"How often have you felt or experienced depressed mood?"

"How often have you felt panicky?"

Mothers were also asked to indicate whether or not they made any of 12 listed cutbacks (food, rent, cutting back on air conditioning, etc.) in previous weeks because of the pandemic. Of these mothers, 52 percent reported being forced to make economic cutbacks, and they reported higher stress, depressive symptoms and anxiety than those who reported not cutting back.

Researchers noted that the immediate economic impacts of the pandemic on low-income Latina mothers' well-being suggests that alleviating families' economic hardship might benefit mothers psychologically. Though the researchers did not find the stimulus payment to buffer the economic or psychological impacts, they suggest the stimulus money was simply not enough.

"Without additional local, state or federal aid, the pandemic is likely to cause severe hardship marked by homelessness, hunger and mental illness. Additional recurring monthly stimulus payments could be a lifeline for families who are struggling to make ends meet," the researchers wrote.

Credit: 
University of California - Davis

UCF engineering and biology researchers collaborate to aid coral reef restoration

image: A uniaxial compression test is performed on Acropora cervicornis coral skeleton.

Image: 
Mahmoud Omer, University of Central Florida

ORLANDO, Jan. 8, 2021 - Florida's threatened coral reefs have a more than $4 billion annual economic impact on the state's economy, and University of Central Florida researchers are zeroing in on one factor that could be limiting their survival - coral skeleton strength.

In a new study published in the journal Coral Reefs, UCF engineering researchers tested how well staghorn coral skeletons withstand the forces of nature and humans, such as impacts from hurricanes and divers.

The researchers subjected coral skeletons to higher stresses than those caused by ocean waves, says Mahmoud Omer, a doctoral student in UCF's Department of Mechanical and Aerospace Engineering and study co-author. "Under normal wave and tide regimes, a staghorn coral's skeleton will resist the physical forces exerted by the ocean waves. However, anthropogenic stressors such as harmful sunscreen ingredients, elevated ocean temperature, pollution and ocean acidification will weaken the coral skeleton and reduce its longevity."

Florida's coral reefs generate billions of dollars in local income, provide more than 70,000 jobs, protect the state's shorelines from storms and hurricanes, and support a diverse ecosystem of marine organisms, according to the U.S. National Oceanic and Atmospheric Administration.

The study uncovered a unique safety feature of the staghorn coral skeleton: Its porous design keeps the coral from being instantly crushed by an impact.

When the UCF engineers subjected skeleton samples to increasing stress, pores relieved the applied load and temporarily stalled further cracking and structural failure. The pores would "pop-in" and absorb some of the applied mechanical energy, thus preventing catastrophic failure. Although this ability has been shown in other coral species, this is the first time it's been demonstrated in staghorn coral.

"For the first time, we used the tools of mechanical engineering to closely examine the skeletons of a critically endangered coral raised in a coral nursery," says John Fauth, an associate professor in UCF's Department of Biology. "We now know more about the structure and mechanical performance of the staghorn coral skeleton than any other coral in the world. We can apply this knowledge to understand why staghorn coral restoration may work in some areas, but where their skeletons may fail due to human and environmental challenges in others."

The results provide baseline values that can be used to judge if nursery-reared staghorn coral have skeletons strong enough for the wild and to match them to areas with environmental conditions that best fit their skeleton strength.

Staghorn coral gets its name from the antler-like shape of its branches, which create an intricate underwater habitat for fish and reef organisms. It primarily is found in shallow waters around the Florida Keys, Puerto Rico, the U.S. Virgin Islands, and other Caribbean islands but has declined by more than 97 percent since the 1980s.

Although restoration efforts using transplanted, nursery-reared coral are underway, scientists continue working to increase their success rate.

Understanding coral skeleton structures also could inform development of skeletal structure replacements for humans, says Nina Orlovskaya, an associate professor in UCF's Department of Mechanical and Aerospace Engineering. "Our findings are of high importance for development of novel and superior biostructures, which can be used as bone graft substitutes," Orlovskaya says. "Coral skeleton structures could be either chemically converted or 3D printed into bio-compatible calcium phosphate ceramics that one day might be directly used to regenerate bones in humans."

In addition to compression tests, the researchers analyzed mechanical properties and spectral and fluidic behavior. The spectral analysis used Raman microscopy, which allowed the researchers to map the effects of compression at the microscopic level in the coral skeleton.

Fluidic behavior analysis revealed that vortices formed around the coral colony helped it to capture food and transport respiratory gases and wastes.

The coral skeletons studied were from Nova Southeastern University's coral nursery, about one mile off the coast of Ft. Lauderdale, near Broward County, Florida. The corals were deceased and were from colonies that failed or were knocked loose during a storm.

Credit: 
University of Central Florida

Large study finds higher burden of acute brain dysfunction for COVID-19 ICU patients

image: Brenda Pun, DNP, RN, Vanderbilt University Medical Center

Image: 
Vanderbilt University Medical Center

COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Choice of sedative medications and curbs on family visitation played a role in increasing acute brain dysfunction for these patients.

That's according to an international study published Jan. 8 in The Lancet Respiratory Medicine, led by researchers at Vanderbilt University Medical Center in coordination with researchers in Spain.

The study, which is far the largest of its kind to date, tracks the incidence of delirium and coma in 2,088 COVID-19 patients admitted before April 28, 2020, to 69 adult intensive care units across 14 countries.

ICU delirium is associated with higher medical costs and greater risk of death and long-term ICU-related dementia. Seminal studies at VUMC over the past two decades have spurred widespread interest in ICU delirium research, and the resulting body of evidence has come to inform critical care guidelines endorsed by medical societies in several countries. These guidelines include well calibrated pain management with prompt discontinuation of analgesics and sedatives, daily spontaneous awakening trials, daily spontaneous breathing trials, delirium assessments throughout the day, early mobility and exercise, and family engagement.

Some 82% of patients in this observational study were comatose for a median of 10 days, and 55% were delirious for a median of three days. Acute brain dysfunction (coma or delirium) lasted for a median of 12 days.

"This is double what is seen in non-COVID ICU patients," said VUMC's Brenda Pun, DNP, RN, co-first author on the study with Rafael Badenes MD, PhD, of the University of Valencia in Spain. The authors cite a previous large, multi-site ICU study, also led by VUMC, where acute brain dysfunction lasted a median of five days, including four days of coma and one day of delirium.

The authors note that COVID-19 disease processes could predispose patient to a higher burden of acute brain dysfunction. But they also note that a number of patient care factors, some of which are related to pressures posed on health care by the pandemic, also appear to have played a significant role.

The study appears to show a reversion to outmoded critical care practices, including deep sedation, widespread use of benzodiazepine infusions (benzodiazepine is a nervous system depressant), immobilization, and isolation from families. The authors find that, where COVID-19 is concerned, there has been an apparent widespread abandonment of newer clinical protocols that are proven to help ward off the acute brain dysfunction that stalks many critically ill patients.

"It is clear in our findings that many ICUs reverted to sedation practices that are not in line with best practice guidelines," Pun said, "and we're left to speculate on the causes. Many of the hospitals in our sample reported shortages of ICU providers informed about best practices.
There were concerns about sedative shortages, and early reports of COVID-19 suggested that the lung dysfunction seen required unique management techniques including deep sedation. In the process, key preventive measures against acute brain dysfunction went somewhat by the boards."

Using electronic health records, investigators were able to closely examine patient characteristics, care practices and findings from clinical assessments. Some 88% of patients tracked in the study were invasively mechanical ventilated at some point during hospitalization, 67% on the day of ICU admission. Patients receiving benzodiazepine sedative infusions were at 59% higher risk of developing delirium. Patients who received family visitation (in-person or virtual) were at 30% lower risk of delirium.

"There's no reason to think that, since the close of our study, the situation for these patients has changed," said one of the study's senior authors, Pratik Pandharipande, MD, MSCI, professor of Anesthesiology.

"These prolonged periods of acute brain dysfunction are largely avoidable. Our study sounds an alarm: as we enter the second and third waves of COVID-19, ICU teams need above all to return to lighter levels of sedation for these patients, frequent awakening and breathing trials, mobilization and safe in-person or virtual visitation."

Credit: 
Vanderbilt University Medical Center

Including unhealthy foods may diminish positive effects of an otherwise healthy diet

Eating a healthy diet, such as the Mediterranean diet, has a positive impact on health, but little is known about the effects of including unhealthy foods in an otherwise healthy diet. Now researchers at Rush University Medical Center have reported diminished benefits of a Mediterranean diet among those with high frequency of eating unhealthy foods. The results of their study were published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association on Jan. 7.

"Eating a diet that emphasizes vegetables, fruit, fish and whole grains may positively affects a person's health," said Puja Agarwal, PhD, a nutritional epidemiologist and assistant professor in the Department of Internal Medicine at Rush Medical College. "But when it is combined with fried food, sweets, refined grains, red meat and processed meat, we observed that the benefits of eating the Mediterranean part of the diet seems to be diminished."

A Mediterranean diet is associated with slower rates of cognitive decline in older adults.

The observational study included 5,001 older adults living in Chicago who were part of the Chicago Health and Aging Project, an evaluation of cognitive health in adults over the age of 65 conducted from 1993 to 2012. Every three years, the study participants completed a cognitive assessment questionnaire that tested basic information processing skills and memory, and they filled out a questionnaire about the frequency with which they consumed 144 food items.

The researchers analyzed how closely each of the study participants adhered to a Mediterranean diet, which includes daily consumption of fruit, vegetables, legumes, olive oil, fish, potatoes and unrefined cereals, plus moderate wine consumption. They also assessed how much each participant followed a Western diet, which included fried foods, refined grains, sweets, red and processed meats, full-fat dairy products and pizza. They assigned scores of zero to five for each food item to compile a total Mediterranean diet score for each participant along a range from zero to 55.

The researchers then examined the association between Mediterranean diet scores and changes in participants' global cognitive function, episodic memory and perceptual speed. Participants with slower cognitive decline over the years of follow-up were those who adhered closest to the Mediterranean diet, along with limiting foods that are part of Western diet, whereas participants who ate more of the Western diet had no beneficial effect of healthy food components in slowing cognitive decline.

There was no significant interaction between age, sex, race or education and the association with cognitive decline in either high or low levels of Western diet foods. The study also included models for smoking status, body mass index and other potential variables such as cardiovascular conditions and findings remained the same.

"Western diets may adversely affect cognitive health," Agarwal said. "Individuals who had a high Mediterranean diet score compared to those who had the lowest score were equivalent to being 5.8 years younger in age cognitively."

Agarwal said that the results complement other studies showing that a Mediterranean diet reduces the risk of heart disease, certain cancers and diabetes and also support previous studies on Mediterranean diet and cognition. The study also notes that most of the dietary patterns that have shown improvement in cognitive function among older adults, including the Mediterranean, MIND, and DASH diets, have a unique scoring matrix based on the amount of servings consumed for each diet component.

"The more we can incorporate green leafy vegetables, other vegetables, berries, olive oil, and fish into our diets, the better it is for our aging brains and bodies. Other studies show that red and processed meat, fried food and low whole grains intake are associated with higher inflammation and faster cognitive decline in older ages," Agarwal said. "To benefit from diets such as the Mediterranean diet, or MIND diet, we would have to limit our consumption of processed foods and other unhealthy foods such as fried foods and sweets."

The study and its findings cannot be readily generalized. Future longitudinal studies on diet and cognition among the middle-aged population are needed to extend these findings.

Credit: 
Rush University Medical Center

New findings help explain how COVID-19 overpowers the immune system

image: Portrait of Pinchas Cohen, MD, Dean of the USC Leonard Davis School of Gerontology

Image: 
Stephanie Kleinman

Seeking to understand why COVID-19 is able to suppress the body’s immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 and identifies key differences in how SARS-CoV-2, the virus that causes COVID-19, affects mitochondrial genes when compared to other viruses. These differences offer possible explanations as to why older adults and people with metabolic disfunction have more severe responses to COVID-19 than other individuals and they also provide a starting point for more targeted approaches that may help identify therapeutics, says senior author Pinchas Cohen, professor of gerontology, medicine and biological sciences and dean of the USC Leonard Davis School.

“If you already have mitochondrial and metabolic dysfunction, then you may, as a result, have a poor first line of defense against COVID-19. Future work should consider mitochondrial biology as a primary intervention target for SARS-CoV-2 and other coronaviruses,” he said.

The study, published in the Nature journal Scientific Reports, expands on recent findings that COVID-19 mutes the body’s innate inflammatory response and reports that it does so by diverting mitochondrial genes from their normal function.

“We already knew that our immune response was not mounting a successful defense to COVID-19, but we didn't know why,” said lead author Brendan Miller, a senior doctoral student at the USC Leonard Davis School. “What we did differently was look at how the virus specifically targets mitochondria, a cellular organelle that is a crucial part of the body’s innate immune system and energy production.”

Making use of the vast amounts of public data being uploaded in the early days of the virus outbreak, the research team performed RNA sequencing analyses that compared mitochondrial-COVID interactions to those of other viruses: respiratory syncytial virus, seasonal influenza A virus, and human parainfluenza virus 3. These reanalyses identified three ways in which COVID-19, but not the other viruses, mutes the body’s cellular protective response.

Chief among their findings is that SARS-CoV-2 uniquely reduces the levels of a group of mitochondrial proteins, known as Complex One, that are encoded by nuclear DNA. It is possible that this effect "quiets" the cell's metabolic output and reactive oxygen species generation, that when functioning correctly, produces an inflammatory response that can kill a virus, they say.

“COVID-19 is reprogramming the cell to not make these Complex One-related proteins. That could be one way the virus continues to propagate,” says Miller, who notes that this, along with the study’s other observations, still needs to be validated in future experiments.

The study also revealed that SARS-CoV-2 does not change the levels of the messenger protein, MAVS mRNA, that usually tells the cell a viral attack has happened. Normally, when this protein gets activated it functions as an alarm system, warning the cell to self-destruct so that the virus cannot replicate, says Miller.

In addition, the researchers found that genes encoded by the mitochondria were not being turned on or off by SARS-CoV-2 - a process that is believed to produce energy that can help the cell evade a virus - at rates to be expected when confronted with a virus.

“This study adds to a growing body of research on mitochondrial-COVID interactions and presents tissue and cell-specific effects that should be carefully considered in future experiments,” said Cohen.

Credit: 
University of Southern California

Bacteria can tell the time

image: Shining a light on internal clocks - the bacterium Bacillus subtilis

Image: 
Professor Ákos Kovács, Technical University of Denmark

Humans have them, so do other animals and plants. Now research reveals that bacteria too have internal clocks that align with the 24-hour cycle of life on Earth.

The research answers a long-standing biological question and could have implications for the timing of drug delivery, biotechnology, and how we develop timely solutions for crop protection.

Biological clocks or circadian rhythms are exquisite internal timing mechanisms that are widespread across nature enabling living organisms to cope with the major changes that occur from day to night, even across seasons.

Existing inside cells, these molecular rhythms use external cues such as daylight and temperature to synchronise biological clocks to their environment. It is why we experience the jarring effects of jet lag as our internal clocks are temporarily mismatched before aligning to the new cycle of light and dark at our travel destination.

A growing body of research in the past two decades has demonstrated the importance of these molecular metronomes to essential processes, for example sleep and cognitive functioning in humans, and water regulation and photosynthesis in plants.

Although bacteria represent 12% biomass of the planet and are important for health, ecology, and industrial biotechnology, little is known of their 24hr biological clocks.

Previous studies have shown that photosynthetic bacteria which require light to make energy have biological clocks.

But free-living non photosynthetic bacteria have remained a mystery in this regard.

In this international study researchers detected free running circadian rhythms in the non-photosynthetic soil bacterium Bacillus subtilis.

The team applied a technique called luciferase reporting, which involves adding an enzyme that produces bioluminescence that allows researchers to visualise how active a gene is inside an organism.

They focused on two genes: firstly, a gene called ytvA which encodes a blue light photoreceptor and secondly an enzyme called KinC that is involved in inducing formation of biofilms and spores in the bacterium.

They observed the levels of the genes in constant dark in comparison to cycles of 12 hours of light and 12 hours of dark. They found that the pattern of ytvA levels were adjusted to the light and dark cycle, with levels increasing during the dark and decreasing in the light. A cycle was still observed in constant darkness.

Researchers observed how it took several days for a stable pattern to appear and that the pattern could be reversed if the conditions were inverted. These two observations are common features of circadian rhythms and their ability to "entrain" to environmental cues.

They carried out similar experiments using daily temperature changes; for example, increasing the length or strength of the daily cycle, and found the rhythms of ytvA and kinC adjusted in a way consistent with circadian rhythms, and not just simply switching on and off in response to the temperature.

"We've found for the first time that non-photosynthetic bacteria can tell the time," says lead author Professor Martha Merrow, of LMU (Ludwig Maximilians University) Munich. "They adapt their molecular workings to the time of day by reading the cycles in the light or in the temperature environment."

"In addition to medical and ecological questions we wish to use bacteria as a model system to understand circadian clock mechanisms. The lab tools for this bacterium are outstanding and should allow us to make rapid progress," she added.

This research could be used to help address such questions as: is the time of day of bacterial exposure important for infection? Can industrial biotechnological processes be optimised by taking the time of day into account? And is the time of day of anti-bacterial treatment important?

"Our study opens doors to investigate circadian rhythms across bacteria. Now that we have established that bacteria can tell the time we need to find out the processes that cause these rhythms to occur and understand why having a rhythm provides bacteria with an advantage," says author Dr Antony Dodd from the John Innes Centre.

Professor Ákos Kovács, co-author from the Technical University of Denmark adds that "Bacillus subtilis is used in various applications from laundry detergent production to crop protection, besides recently exploiting as human and animal probiotics, thus engineering a biological clock in this bacterium will culminate in diverse biotechnological areas."

Credit: 
John Innes Centre

Perceiving prosthesis as lighter thanks to neurofeedback

image: Prosthesis with sensors on sole

Image: 
ETH Zurich

Leg amputees are often not satisfied with their prosthesis, even though the sophisticated prostheses are becoming available. One important reason for this is that they perceive the weight of the prosthesis as too high, despite the fact that prosthetic legs are usually less than half the weight of a natural limb. Researchers led by Stanisa Raspopovic, a professor at the Department of Health Sciences and Technology, have now been able to show that connecting the prostheses to the nervous system helps amputees to perceive the prosthesis weight as lower, which is beneficial for their acceptance.

Together with an international consortium, Raspopovic has developed in recent years prostheses that provide feedback to the wearer's nervous system. This is done via electrodes implanted in the thigh, which are connected to the leg nerves present there. Information from tactile sensors under the sole of the prosthetic foot and from angle sensors in the electronic prosthetic knee joint are converted into pulses of current and passed in to the nerves.

"To trick an above-knee amputee's brain into the belief that the prosthetic leg was similar to his own leg, we artificially restored the lost sensory feedback," says ETH professor Raspopovic. In a study published last year, he and his team showed that wearers of such neurofeedback prostheses can move more safely and with less effort.

In a further study, the scientists were now able to show that neurofeedback also reduces the perceived weight of the prosthesis. They published the results in the journal Current Biology

In order to determine how heavy a transfemoral amputee perceives their prosthetic leg to be, they had a voluntary study participant complete gait exercises with either neurofeedback switched on or off. They weighed down the healthy foot with additional weights and asked the study participant to rate how heavy he felt the two legs were in relation to each other. Neurofeedback was found to reduce the perceived weight of the prosthesis by 23 percent, or almost 500 grams.

The scientists also confirmed a beneficial involvement of the brain by a motor-cognitive task, during which the volunteer had to spell backwards five-letter words while walking. The sensory feedback not only allowed him to have a faster gait but also to have a higher spelling accuracy.

"Neurofeedback not only enables faster and safer walking and positively influences weight perception," says Raspopovic. "Our results also suggest that, quite fundamentally, it can take the experience of patients with an artificial device closer to that with a natural limb."

Credit: 
ETH Zurich

Antibiotic resistance from random DNA sequences

An important and still unanswered question is how new genes that cause antibiotic resistance arise. In a new study, Swedish and American researchers have shown how new genes that produce resistance can arise from completely random DNA sequences. The results have been published in the journal PLOS Genetics.

Antibiotic resistance is a major global problem and the spread of resistant bacteria causes disease and death, and constitutes a major cost to society. The most common way for bacteria to develop resistance is by taking up various types of resistance genes from other bacteria. These genes encode proteins (peptides) that can lead to resistance by: (i) deactivating the antibiotic, (ii) reducing its concentration, or (iii) altering the antibiotic's target so that the antibiotic can no longer bind to that target and hence halt the growth of the bacterium. Once resistance genes have arisen, they can quickly spread between different pathogenic bacteria and reduce the effectiveness of our antibiotics. It is therefore important to detect and characterise new resistance genes as quickly as possible - in order to monitor the spread of resistance and also to facilitate treatment and the development of new antibiotics.

To study the emergence of resistance genes, the researchers used laboratory experiments to investigate whether it was possible to generate a gene from random DNA sequences that would give rise to antibiotic resistance. This was done by first designing nearly one billion random DNA sequences that were then placed on a plasmid in the intestinal bacterium Escherichia coli. (Plasmids are DNA molecules that replicate independently and can be transferred from one organism to another.)

These random DNA sequences were then expressed in the bacterium as short peptides. While most of these peptides had no effect on the bacterium at all, six different peptides did, causing the bacterium to become resistant to the antibiotic Colistin, an important antibiotic medication of last resort that is used in severe infections to kill the bacteria by binding to and destroying the bacterium's cell membrane. These peptides caused resistance by increasing the expression of genes that are involved in the modification of the bacterium's cell membrane. This modification of the cell membrane resulted in the antibiotic not being able to bind to cell membrane, and thus not being able to reduce the survival of the bacterium.

"We have now shown in two different studies that random sequences of amino acids can give rise to new functions that are beneficial to the bacterium such as antibiotic resistance. This suggests that the evolution of new functions from random DNA sequences is not as unusual as previously thought," says Dan I. Andersson, Professor in Medical Bacteriology and responsible for the study.

"An important question that remains unanswered and requires further study is whether these new genes are naturally present in bacteria or can only be observed in laboratory experiments," says Michael Knopp, post-doctoral researcher at the Department of Medical Biochemistry and Microbiology and the study's first author.

Credit: 
Uppsala University

Detecting COVID-19 antibodies in 10-12 seconds

image: An image of the COVID-19 test chip made by aerosol jet nanoparticle 3D printing.

Image: 
Advanced Manufacturing and Materials Lab, College of Engineering, Carnegie Mellon University

PITTSBURGH--Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. In addition to testing, the platform will help to quantify patient immunological response to the new vaccines with precision.

The results were published this week in the journal Advanced Materials. Carnegie Mellon's collaborators included the University of Pittsburgh (Pitt) and the UPMC.

The testing platform identifies the presence of two of the virus' antibodies, spike S1 protein and receptor binding domain (RBD), in a very small drop of blood (about 5 microliters). Antibody concentrations can be extremely low and still detected below one picomolar (0.15 nanograms per milliliter). This detection happens through an electrochemical reaction within a handheld microfluidic device which sends results almost immediately to a simple interface on a smart phone.

"We utilized the latest advances in materials and manufacturing such as nanoparticle 3D printing to create a device that rapidly detects COVID-19 antibodies," said Rahul Panat, an associate professor of mechanical engineering at Carnegie Mellon who uses specialized additive manufacturing techniques for research ranging from brain-computer interfaces to biomonitoring devices.

An additive manufacturing technology called aerosol jet 3D printing is responsible for the efficiency and accuracy of the testing platform. Tiny, inexpensive gold micropillar electrodes are printed at nanoscale using aerosol droplets that are thermally sintered together. This causes a rough, irregular surface that provides increased surface area of the micropillars and an enhanced electrochemical reaction, where antibodies can latch on to antigens coated on the electrode. The specific geometry allows the micropillars to load more proteins for detection, resulting in very accurate, quick results.

The test has a very low error rate because the binding reaction between the antibody and antigen used in the device is highly selective. The researchers were able to exploit this natural design to their advantage.

The results come at an urgent time during the COVID-19 pandemic. "Because our technique can quantify the immune response to vaccination, it is very relevant in the current environment," Panat said.

Panat collaborated with Shou-Jiang Gao, leader of the cancer virology program at UPMC's Hillman Cancer Center and professor of microbiology and molecular genetics at Pitt. Azahar Ali, a researcher in Panat's Advanced Manufacturing and Materials Lab, was the lead author of the study.

Rapid diagnosis for the treatment and prevention of communicable diseases is a public health issue that goes beyond the current COVID-19 pandemic. Because the proposed sensing platform is generic, it can be used for the rapid detection of biomarkers for other infectious agents such as Ebola, HIV, and Zika. Such a quick and effective test could be a game-changer for controlling the spread of diseases.

Credit: 
College of Engineering, Carnegie Mellon University

Nanocrystals that eradicate bacteria biofilm

image: Schematic diagram showing removal of bacterial biofilm via Mtex

Image: 
POSTECH

The COVID-19 pandemic is raising fears of new pathogens such as new viruses or drug-resistant bacteria. To this, a Korean research team has recently drawn attention for developing the technology for removing antibiotic-resistant bacteria by controlling the surface texture of nanomaterials.

A joint research team from POSTECH and UNIST has introduced mixed-FeCo-oxide-based surface-textured nanostructures (MTex) as highly efficient magneto-catalytic platform in the international journal Nano Letters. The team consisted of professors In Su Lee and Amit Kumar with Dr. Nitee Kumari of POSTECH's Department of Chemistry and Professor Yoon-Kyung Cho and Dr. Sumit Kumar of UNIST's Department of Biomedical Engineering.

First, the researchers synthesized smooth surface nanocrystals in which various metal ions were wrapped in an organic polymer shell and heated them at a very high temperature. While annealing the polymer shell, a high-temperature solid-state chemical reaction induced mixing of other metal ions on the nanocrystal surface, creating a number of few-nm-sized branches and holes on it. This unique surface texture was found to catalyze a chemical reaction that produced reactive oxygen species (ROS) that kills the bacteria. It was also confirmed to be highly magnetic and easily attracted toward the external magnetic field. The team had discovered a synthetic strategy for converting normal nanocrystals without surface features into highly functional mixed-metal-oxide nanocrystals.

The research team named this surface topography - with branches and holes that resembles that of a ploughed field - "MTex." This unique surface texture has been verified to increase the mobility of nanoparticles to allow efficient penetration into biofilm matrix while showing high activity in generating reactive oxygen species (ROS) that are lethal to bacteria.

This system produces ROS over a broad pH range and can effectively diffuse into the biofilm and kill the embedded bacteria resistant to antibiotics. And since the nanostructures are magnetic, biofilm debris can be scraped out even from the hard-to-reach microchannels.

"This newly developed MTex shows high catalytic activity, distinct from the stable smooth-surface of the conventional spinel forms," explained Dr. Amit Kumar, one of the corresponding authors of the paper. "This characteristic is very useful in infiltrating biofilms even in small spaces and is effective in killing the bacteria and removing biofilms."

"This research allows to regulate the surface nanotexturization, which opens up possibilities to augment and control the exposure of active sites," remarked Professor In Su Lee who led the research. "We anticipate the nanoscale-textured surfaces to contribute significantly in developing a broad array of new enzyme-like properties at the nano-bio interface."

Credit: 
Pohang University of Science & Technology (POSTECH)

Study: Religion, psychology share methods for reducing distress

image: Psychology professors Sanda Dolcos, left, and Florin Dolcos led a study of religiosity and emotion-regulation strategies among healthy adults.

Image: 
Photo by L. Brian Stauffer

CHAMPAIGN, Ill. -- Religious people facing life crises rely on emotion-regulation strategies that psychologists also use, a new study finds. They look for positive ways of thinking about hardship, a practice known to psychologists as "cognitive reappraisal." They also tend to have confidence in their ability to cope with difficulty, a trait called "coping self-efficacy." Both have been shown to reduce symptoms of anxiety and depression.

The new findings are reported in the Journal of Religion and Health.

"It appears that religious people are making use of some of the same tools that psychologists have systematically identified as effective in increasing well-being and protecting against distress," said Florin Dolcos, a professor of psychology in the Beckman Institute for Advanced Science and Technology at the University of Illinois Urbana-Champaign, who led the study with psychology professor Sanda Dolcos and graduate student Kelly Hohl. "This suggests that science and religion are on the same page when it comes to coping with hardship," he said.

The research was prompted in part by earlier studies demonstrating that people who are religious tend to use a coping strategy that closely resembles cognitive reappraisal.

"For example, when somebody dies, a religious person may say, 'OK, now they are with God,' while someone who isn't religious may say, 'Well, at least they are not suffering anymore,'" Florin Dolcos said. In both cases, the individual finds comfort in framing the situation in a more positive light.

To determine if religious people rely on - and benefit from - reappraisal as an emotion-regulation strategy, the researchers recruited 203 participants with no clinical diagnoses of depression or anxiety. Fifty-seven of the study subjects also answered questions about their level of religiosity or spirituality.

The researchers asked participants to select from a series of options describing their attitudes and practices.

"We asked them about their coping styles. So, for religious coping, we asked if they try to find comfort in their religious or spiritual beliefs," Hohl said. "We asked them how often they reappraise negative situations to find a more positive way of framing them or whether they suppress their emotions."

The researchers also evaluated participants' confidence in their ability to cope and asked them questions designed to measure their symptoms of depression and anxiety.

Hohl said she looked for correlations between coping strategies, religious or nonreligious attitudes and practices, and levels of distress. She also conducted a mediation analysis to determine which practices specifically influenced outcomes like depression or anxiety.

"If we are just looking at the relationship between religious coping and lower anxiety, we don't know exactly which strategy is facilitating this positive outcome," Sanda Dolcos said. "The mediation analysis helps us determine whether religious people are using reappraisal as an effective way of lessening their distress."

The analysis also shows whether an individual's confidence in their ability to handle crises - another factor that psychological studies have found is associated with less depression and anxiety - "facilitates the protecting role of religious coping against such symptoms of emotional distress," Sanda Dolcos said. "We found that if people are using religious coping, then they also have decreased anxiety or depressive symptoms."

Cognitive reappraisal and coping self-efficacy were contributing to those decreased symptoms of distress, she said.

The study should be of interest to clinical psychologists working with religious clients, Hohl said. "It should also speak to clergy members or church leaders who can promote this kind of reappraisal to help parishioners make sense of the world and increase their resilience against stress."

"I hope this is an example of where religion and science can work together to maintain and increase well-being," Florin Dolcos said.

Credit: 
University of Illinois at Urbana-Champaign, News Bureau

Understanding how to improve antibodies targeting OX40 for the treatment of cancer

image: Human T-Cell

Image: 
NIAID

Scientists at the University of Southampton's Centre for Cancer Immunology have gained new insight into how the immune system can be better used to find and kill cancer cells.

Working with BioInvent International, a team led by Professor Mark Cragg and Dr Jane Willoughby from the Antibody and Vaccine Group, based at the Centre, have shown that antibodies, designed to target the molecule OX40, give a more active immune response when they bind closer to the cell membrane and can be modified to attack cancer in different ways.

OX40 is a 'co-receptor' that helps to stimulate the production of helper and killer T-cells during an immune response. One of the ways cancer avoids detection is by suppressing immune responses to stop functional tumour specific T-cells from being produced.

In the study, which has been published in Journal for ImmunoTherapy of Cancer, the team also discovered that switching the antibody's isotype (the part of the antibody that engages with cells of the immune system) could change the way the antibody worked.

When the mIgG2a isotype was used, the antibody could delete cells called Treg cells which are suppressive in the immune system. When the mIgG1 isotype was present, the antibody could stimulate killer T-cells to increase and therefore kill more cancer cells.

Professor Cragg said: "Clinical trials with anti-OX40 antibodies have shown that the body can tolerate these drugs but unfortunately have also shown disappointing clinical responses. We need to understand why this is.

"This new data shows us that when there is a cancer with lots of Tregs we could use the equivalent of the m2IgGa isotype and in patients where we feel we need better cytotoxic T cells we could use the equivalent of a mIgG1 isotype to boost the immune response. This information is important for developing the next generation of OX40 antibodies that we hope will be more effective in treating patients with cancer."

Credit: 
University of Southampton

How 'Iron Man' bacteria could help protect the environment

image: This Geobacter cell -- which looks a bit like a gray peanut in this microscope image -- is speckled with a dark coating of cobalt minerals that would be toxic to many organisms.

Image: 
Hunter Dulay, MSU

When Michigan State University's Gemma Reguera first proposed her new research project to the National Science Foundation, one grant reviewer responded that the idea was not "environmentally relevant."

As other reviewers and the program manager didn't share this sentiment, NSF funded the proposal. And, now, Reguera's team has shown that microbes are capable of an incredible feat that could help reclaim a valuable natural resource and soak up toxic pollutants.

"The lesson is that we really need to think outside the box, especially in biology. We just know the tip of the iceberg. Microbes have been on earth for billions of years, and to think that they can't do something precludes us from so many ideas and applications," said Reguera, a professor in the Department of Microbiology and Molecular Genetics.

Reguera's team works with bacteria found in soil and sediment known as Geobacter. In its latest project, the team investigated what happened to the bacteria when they encounter cobalt.

Cobalt is a valuable but increasingly scarce metal used in batteries for electric vehicles and alloys for spacecraft. It's also highly toxic to livings things, including humans and bacteria.

"It kills a lot of microbes," Reguera said. "Cobalt penetrates their cells and wreaks havoc."

But the team suspected Geobacter might be able to escape that fate. These microbes are a hardy bunch. They can block uranium contaminants from getting into groundwater, and they can power themselves by pulling energy from minerals containing iron oxide. "They respire rust," Reguera said.

Scientists know little about how microbes interact with cobalt in the environment, but many researchers -- including one grant reviewer -- believed that the toxic metal would be too much for the microbes.

But Reguera's team challenged that thinking and found Geobacter to be effective cobalt "miners," extracting the metal from rust without letting it penetrate their cells and kill them. Rather, the bacteria essentially coat themselves with the metal.

"They form cobalt nanoparticles on their surface. They metallize themselves and it's like a shield that protects them," Reguera said. "It's like Iron Man when he puts on the suit."

The team published its discovery in the journal Frontiers in Microbiology, with the research article first appearing online in late November, 2020. The Spartan team included Kazem Kashefi, an assistant professor in the Department of Microbiology and Molecular Genetics, and graduate students Hunter Dulay and Marcela Tabares, who are "two amazing and relatively junior investigators," Reguera said.

She sees this discovery as a proof-of-concept that opens the door to a number of exciting possibilities. For example, Geobacter could form the basis of new biotechnology built to reclaim and recycle cobalt from lithium-ion batteries, reducing the nation's dependence on foreign cobalt mines.

It also invites researchers to study Geobacter as a means to soak up other toxic metals that were previously believed to be death sentences for the bacteria. Reguera is particularly interested in seeing if Geobacter could help clean up cadmium, a metal that's found in industrial pollution that disproportionately affects America's most disadvantaged communities.

"This is a reminder to be creative and not limited in the possibilities. Research is the freedom to explore, to search and search and search," Reguera said. "We have textbook opinions about what microbes can and should do, but life is so diverse and colorful. There are other processes out there waiting to be discovered."

Credit: 
Michigan State University